OLMA Overview
Upcoming Projects (OLMA)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (OLMA)
-
Discussing highlights from ESMO in breast cancer: Pfizer's CDK4-selective inhibitor PF-07220060, Arvinas/Pfizer Vepdegestrant/palbociclib combo & Olema's palazestrant/ribociclib combo
Tickers: PFE, ARVN, OLMA
Executed On: Jun 10, 2024 at 09:00 AM EDT
Upcoming & Overdue Catalysts (OLMA)
-
OLMA OP-1250 Data.
Ticker: OLMA
Future Window: Oct 01, 2023 - Dec 31, 2023
Overdue -
ARV-471 Phase 3 trial
Tickers: ARVN, PFE, OLMA
Future Window: Oct 01, 2023 - Dec 31, 2024
Occurred Catalysts (OLMA)
-
Olema Oncology (OLMA) Announces Phase 1/2 Clinical Data on OP-1250 in Advanced ER+ / HER2- Breast Cancer
Ticker: OLMA
Occurred on: Nov 30, 2021
Strategic Initiatives (OLMA)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
